Linking etiologies in humans and animal models: Studies of autism

Reproductive Toxicology

Volumn 11, Issue 2-3, 1997, Pages 417-422

  Rodier, Patricia M ^a,b   Ingram, Jennifer L ^a   Tisdale, Barbara ^a   Croog, Victoria J ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

brain stem; cerebellum; facial nucleus; superior olive; teratology; thalidomide; valproic acid

Indexed keywords

TERATOGENIC AGENT; THALIDOMIDE; VALPROIC ACID;

ANIMAL; ANIMAL MODEL; AUTISM; AUTOPSY; BRAIN; BRAIN STEM INJURY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONGENITAL DEAFNESS; CONTROLLED STUDY; CRANIAL NERVE; DRUG EFFECT; DUANE RETRACTION SYNDROME; EAR MALFORMATION; EMBRYO; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; MOEBIUS SYNDROME; MOTONEURON NUCLEUS; MOUSE; NERVE INJURY; NEURAL TUBE DEFECT; NONHUMAN; PATHOLOGY; PREGNANCY; PRENATAL DRUG EXPOSURE; RAT; TEGMENTUM; TERATOGENESIS;

ANIMALIA;

EID: 0031104734     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)80001-U     Document Type: Conference Paper

References (24)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC; 1994.
2. Bryson SE, Clark BS, Smith IM. First report of a Canadian epidemiological study of autistic syndromes. J Child Psychol Psychiatry. 1988;29:433-45.
3. Bryson SE. personal communication.
4. Folstein SE, Rutter ML. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977;18:297-321.
5. Piven J, Folstein SE. The genetics of autism. In Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press; 1994:18-44.
6. Bauman ML, Kemper TL. Neuroanatomic observations in autism. In Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press; 1994:119-45.
7. Courchesne E, Townsend J, Saitch O. The brain in infantile autism: posterior fossa structures are abnormal. Neurology. 1994;44:214-28.
8. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y. Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord. 1995;25:1-18.
9. Miller MT, Strömland K. Thalidomide embryopathy: an insight into autism? Teratology. 1993;47:387-8.
10. Strömland K, Nordin V, Miller MT, Akerstrom B, Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol. 1994;36:351-6.
11. Miller MT. Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus. Trans Am Ophthalmol Soc. 1991;89:623-74.
12. d'Avignon M, Barr B. Ear abnormalities and cranial nerve palsies in thalidomide children. Arch Otolaryngol. 1964;80:136-40.
13. Lenz W. Thalidomide and congenital abnormalities. Lancet 1962;1:271-2.
14. Walker HA. Incidence of minor physical anomaly in autism. J Aut Child Schiz. 1977;7:165-76.
15. Scharre JE, Creedon MP. Assessment of visual function in autistic children. Optom Vis Sci. 1992;69:433-9.
16. Gillberg C, Steffenberg S. Autistic behavior in Moebius syndrome. Acta Pediatr Scand. 1989;78:314-6.
17. Rodier PM, Ingram, JL, Tisdale B, Nelson S, Romano J. An embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol. 1996;370:247-261.
18. Coleman PD, Romano J, Lapham LW, Simon W. Cell counts in the cerebral cortex of an autistic patient. J Autism Dev Disord. 1985;15:245-55.
19. Carpenter EM, Goddard JM, Chisaka O, Manley NR, Capecchi MR. Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development. 1993;118:1063-75.
20. Mark M, Lufkin T, Vonesch J-L, Ruberte E, Olivo, J-L, Dollé P, Gorry P, Lumsden A, Chambon P. Two rhombomeres are altered in Hoxa-1 mutant mice. Development. 1993;119:319-38.
21. Schumacher HJ, Terapane J, Jordan RL, Wilson JG. The teratogenic activity of a thalidomide analogue, EM12, in rabbits, rats, and monkeys. Teratology. 1968;5:233-40.
22. Binkerd PE, Rowland JM, Nau H, Hendrickx AG. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam Appl Toxicol. 1988;11:485-93.
23. Ardinger HH, Atkin JF, Blackston, RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ, Majewski F, Schinzel A, Toriello HV, Hanson JW. Verification of the fetal valproate syndrome phenotype. Am J Med Genet. 1988; 29:171-85.
24. Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol. 1994;36:357-69.